TABLE 1.
Country | Number (%) of Population With HCV Infection | Diagnosed 2019 | Diagnosed Accumulated | Treated 2019 | Accumulated Treated | Goal 90% Diagnosis | Goal Treat 80% | Goal Decrease 65% Mortality | Goal Decrease 90% Incidence |
---|---|---|---|---|---|---|---|---|---|
Argentina | 326,000 (0.8%) | 9% | 3% | 1% | 3% | >2051 | >2051 | >2051 | 2048 |
Brazil | 1,787,000 (0.9%) | 8% | 31% | 2% | 25% | 2035 | 2029 | 2034 | 2038 |
Chile | 56,500 (0.3%) | 10% | 19% | <1% | 1% | >2051 | >2051 | >2051 | >2051 |
Colombia | 409,000 (0.8%) | 9% | 13% | <1% | 1% | >2051 | >2051 | >2051 | >2051 |
Cuba | 35,000 (0.3%) | 56% | ND | <1% | 1% | 2028 | >2051 | >2051 | >2051 |
Dominican Republic | 68,200 (0.6%) | 12% | 14% | 1% | 4% | >2051 | >2051 | >2051 | >2051 |
El Salvador | 32,300 (0.5%) | 3% | 9% | ND | ND | >2051 | >2051 | >2051 | >2051 |
Mexico | 532,000 (0.4%) | 49% | 53% | <1% | 2% | 2037 | >2051 | >2051 | >2051 |
Peru | 167,000 (0.5%) | 11% | 15% | 1% | 5% | >2051 | >2051 | >2051 | >2051 |
Venezuela | 118,000 (0.4%) | 25% | ND | ND | 2% | >2051 | >2051 | >2051 | >2051 |